Biotek-snakken — Oktober 2025
-
-
Diamyd Medical - Et muligt gennembrud i type 1-diabetes - indlæg på Proinvestor. https://proinvestor.com/boards/128660/
-
Flere dages kursstigninger - er trenden positiv? Genmab, Novo Nordisk, Zealand Pharma, Gubra . Kort video: https://proinvestor.com/boards/128686
-
Hong Kong grants precision medicine patent to Diamyd Medical for insulin antigen treatment in type 1 diabetes - https://www.diamyd.com/docs/pressClips.aspx?ClipID=5225307
-
Poster på Nadunolimab fra fra Cantargia. https://cantargia.comhttps://nbg1.your-objectstorage.com/proinvestor-dev/forum/AACR-PDAC-B091-Rydberg-Millrud-et-al.pdf
-
https://cantargia.comhttps://nbg1.your-objectstorage.com/proinvestor-dev/forum/AACR-PDAC-B006-Marsh-et-al.pdf
-
Virogates tager markant kurshop på købstilbud https://proinvestor.com/investornyt/1368950/virogates-tager-markant-kurshop-pa-kobstilbud
-
Wall Street reacts as Johnson & Johnson circles Protagonist
Explore how Johnson & Johnson’s bid to acquire Protagonist Therapeutics could reshape its immunology and hematology pipeline—details inside.
Business-News-Today.com (business-news-today.com)
-
4 Healthcare Stocks to Buy Now https://proinvestor.com/investornyt/1370221/4-healthcare-stocks-to-buy-now
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
